Cancer Statistics, 2021.
Reads0
Chats0
TLDR
In the United States, the cancer death rate has dropped continuously from its peak in 1991 through 2018, for a total decline of 31%, because of reductions in smoking and improvements in early detection and treatment as mentioned in this paper.Abstract:
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence. Incidence data (through 2017) were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2018) were collected by the National Center for Health Statistics. In 2021, 1,898,160 new cancer cases and 608,570 cancer deaths are projected to occur in the United States. After increasing for most of the 20th century, the cancer death rate has fallen continuously from its peak in 1991 through 2018, for a total decline of 31%, because of reductions in smoking and improvements in early detection and treatment. This translates to 3.2 million fewer cancer deaths than would have occurred if peak rates had persisted. Long-term declines in mortality for the 4 leading cancers have halted for prostate cancer and slowed for breast and colorectal cancers, but accelerated for lung cancer, which accounted for almost one-half of the total mortality decline from 2014 to 2018. The pace of the annual decline in lung cancer mortality doubled from 3.1% during 2009 through 2013 to 5.5% during 2014 through 2018 in men, from 1.8% to 4.4% in women, and from 2.4% to 5% overall. This trend coincides with steady declines in incidence (2.2%-2.3%) but rapid gains in survival specifically for nonsmall cell lung cancer (NSCLC). For example, NSCLC 2-year relative survival increased from 34% for persons diagnosed during 2009 through 2010 to 42% during 2015 through 2016, including absolute increases of 5% to 6% for every stage of diagnosis; survival for small cell lung cancer remained at 14% to 15%. Improved treatment accelerated progress against lung cancer and drove a record drop in overall cancer mortality, despite slowing momentum for other common cancers.read more
Citations
More filters
Journal ArticleDOI
Redox Control of the Dormant Cancer Cell Life Cycle.
TL;DR: In this article, the underlying molecular basis of redox signaling in the cell life cycle of dormant cancer and the potential redox-based targeting strategies for eliminating dormant cancer cells are discussed.
Journal ArticleDOI
Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
Hui-Xian Xu,Chen-Xi Cao,Yuqing Ren,Siyuan Weng,Long Liu,C-C Guo,Libo Wang,Xinwei Han,Jianzhuang Ren,Zaoqu Liu +9 more
TL;DR: This review systematically summarizes the role of microbes and their metabolites in the regulation of tumor immunity and highlights the mechanism of action of FMT in the treatment of refractory tumors as well as in improving the efficacy of immunotherapy.
Journal ArticleDOI
Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression
Xiaodan Mao,Huifang Lei,Tian-hong Yi,Pin-Wen Su,Shuting Tang,Yao Tong,Binhua Dong,Guanyu Ruan,Alexander Mustea,Jalid Sehouli,Pengming Sun +10 more
TL;DR: In this paper , the authors investigated the underlying mechanism of ERRα-mediated lipid reprogramming in endometrial cancer (EC) progression by using dual-luciferase reporter and chromatin immunoprecipitation quantitative polymerase chain reaction (ChIP-qPCR).
Journal ArticleDOI
Effect of an Antiracism Intervention on Racial Disparities in Time to Lung Cancer Surgery
TL;DR: In this article , the authors conducted a secondary analysis of the Accountability for Cancer Care through Undoing Racism and Equity, an antiracism prospective pragmatic trial at five cancer centers to assess the impact on overall timeliness of lung cancer surgery and racial disparities in timely surgery.
Journal ArticleDOI
Advancing Tissue Decellularized Hydrogels for Engineering Human Organoids
Beatriz S. Moura,Maria V. Monteiro,Luís P. Ferreira,Pedro Lavrador,Vítor M. Gaspar,João F. Mano +5 more
TL;DR: The most recent advances in the bioengineering of decellularized tissue hydrogels for generating organoids and assembloids are showcased, highlighting the importance of the supporting matrix.
References
More filters
Journal ArticleDOI
Cancer statistics, 2019.
TL;DR: The overall cancer death rate dropped continuously from 1991 to 2016 by a total of 27%, translating into approximately 2,629,200 fewer cancer deaths than would have been expected if death rates had remained at their peak.
Journal ArticleDOI
Cancer statistics, 2016
TL;DR: Overall cancer incidence trends are stable in women, but declining by 3.1% per year in men, much of which is because of recent rapid declines in prostate cancer diagnoses, and brain cancer has surpassed leukemia as the leading cause of cancer death among children and adolescents.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.
Journal ArticleDOI
Sex differences in immune responses
Sabra L. Klein,Katie L. Flanagan +1 more
TL;DR: It is emphasized that sex is a biological variable that should be considered in immunological studies and contribute to variations in the incidence of autoimmune diseases and malignancies, susceptibility to infectious diseases and responses to vaccines in males and females.
Journal ArticleDOI
Colorectal cancer statistics, 2020.
Rebecca L. Siegel,Kimberly D. Miller,Ann Goding Sauer,Stacey A. Fedewa,Lynn F. Butterly,Lynn F. Butterly,Joseph C. Anderson,Joseph C. Anderson,Andrea Cercek,Robert A. Smith,Ahmedin Jemal +10 more
TL;DR: Progress against CRC can be accelerated by increasing access to guideline‐recommended screening and high‐quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle‐aged adults.